Iron nanoparticle injection for advanced solid tumors
Part of Cancer, Digestive system, Hormones & metabolism, Lungs & breathing, Women’s health & pregnancy clinical trials.
This trial tests a new treatment for advanced solid tumors that uses tiny iron particles guided by carbon nanoparticles, injected directly into the tumor. It may be an option if standard treatments have stopped working or aren't available, and you have a tumor that can be safely injected.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an advanced solid tumor (like lung, breast, colon, or pancreatic cancer) that hasn't responded to standard treatments or for which no standard treatment exists.
- You have at least one tumor that can be safely injected with the study drug, and it's measurable on imaging scans.
- You are between 18 and 80 years old, and your overall health is good enough to be up and about (ECOG score 0-1).
- Your blood counts, kidney and liver function are within acceptable limits, and your heart function is normal (LVEF ≥ 50%).
- You are not pregnant, and you agree to use effective contraception during and for 6 months after treatment.
- You do not have conditions that affect iron metabolism (like thalassemia or G6PD deficiency), active brain metastases, or uncontrolled infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding special immune cells (iNKT cells and CD8+ T cells) given by IV infusion can help treat advanced cancers. It mainly looks at safety first, and also checks whether the treatment can shrink or control cancer.
This trial tests an experimental cell therapy (HS-IT101) for people with advanced solid tumors that have not responded to standard treatments. It uses immune cells from your own tumor to fight cancer, and researchers want to see if it is safe and effective.
This Phase 1 trial tests GT101, an injection made from your own tumor-fighting immune cells, for advanced solid cancers that can’t be removed with surgery. It’s mainly aimed at checking safety and early signs of whether the treatment may work.
This trial tests a new drug that targets tumors with a specific marker you can see on a PET scan. It is for people whose cancer has spread or come back after standard treatments, and it may help shrink tumors or slow their growth.
This trial tests a new treatment that injects tiny carbon-iron particles directly into a tumor, combined with radiation therapy, to see if it helps control solid tumors. It is for people who are either getting radiation before surgery or as their main treatment when surgery isn't an option.
This trial tests a new drug that may help people with advanced solid tumors that have not responded to other treatments. The drug is given as an injection and aims to stop cancer growth.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.